Female Sexual Dysfunction Clinical Trial
Official title:
Sexual Dysfunction and an Educational Program to Improve the Quality of Sexual Function in Vietnamese Pregnant Women in First Trimester
Sexual dysfunction is common in pregnant women (46.6%, 34.4%, and 73.3% in women in the first, second, and third trimester worldwide, respectively). These dysfunctions can persist after childbirth, affecting quality of life, marriage satisfaction, and family happiness. In Vietnam, a country heavily influenced by the Eastern traditions, sexual activity is considered private and only shared between husband and wife. Many women have wrong beliefs that having sexual intercouse during pregnancy will affect the safety of the fetus, and thus, are reluctant to engage in sexual activity with their husband. Interventions have been developed to improve the quality of sexual function in pregnant women. In Vietnam, data of sexual dysfunction in pregnant women are somewhat limited, and there have been no programs to improve the sexual function for this population. Therefore, the study team plans to develop an educational program with aim to improve the quality of sexual function in Vietnamese pregnant women. This study aims to investigate the prevalence and associated factors of sexual dysfunction in first-trimester pregnant women and evaluate the effectiveness of the educational program.
Status | Recruiting |
Enrollment | 350 |
Est. completion date | December 1, 2021 |
Est. primary completion date | October 1, 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Pregnant women whose gestational age is less than or equal to 12 weeks. - Currently living with husband/partner. - No signs and symptoms of first trimester complications (eg, threated abortion). Exclusion Criteria: - Getting pregnant from in vitro fertilization or having a history of preterm birth. - Having serious health conditions that require abortion. - Illiterate, or having mental illness or incapacity. - Having a fetus diagnosed with anomalies. - Does not agree to participate. |
Country | Name | City | State |
---|---|---|---|
Vietnam | National Hospital of Obstetrics and Gynecology | Hanoi |
Lead Sponsor | Collaborator |
---|---|
National Hospital of Obstetrics and Gynecology |
Vietnam,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Prevalence of sexual dysfunction in pregnant women | Sexual function is evaluated using the Female Sexual Function Index (FSFI). The FSFI includes 19 questions covering six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. Questions ask about participant's sexual experience during the past four weeks, rating the degree/frequency of their experience on a scale from "not at all" or "never" to "very" or "always". Four questions score 1-5 and fifteen score 0-5. Then, the scores of questions in an individual domain are added and the total score is multiplied by the domain factor. Finally, the six domain scores are added to obtain the full scale score. A total FSFI score of <= 26.55 is considered sexual dysfunction. | Baseline | |
Primary | Change in the FSFI score from baseline to two months | Patients are followed up after two months and repeated the FSFI. The difference between the baseline total FSFI score and the two-month total FSFI score is calculated. The mean difference is calculated for the intervention and the control arm. | Two months | |
Secondary | Change in knowledge and attitude at two months | Knowledge and attitude are assessed by asking participants whether they agree or disagree with 24 statements. These statements are developed based on the key messages of the educational program. K/A assessment is repeated at two months. We calculate the proportion of participants who have changes in knowledge and attitude after the educational program. | Two months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05806424 -
Investigation of Awareness Levels of Women Living in Turkey About Kegel Exercises and Pelvic Floor Muscles
|
||
Completed |
NCT01364623 -
PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women
|
Phase 1 | |
Completed |
NCT06060691 -
the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction
|
Phase 1 | |
Completed |
NCT04122703 -
Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction
|
N/A | |
Recruiting |
NCT03498443 -
Effect of Pelvic Organ Prolapse Surgeries on Female Sexual Function in Egyptian Women
|
||
Completed |
NCT03232801 -
A Mindfulness-based Intervention for Older Women With Low Sexual Desire
|
N/A | |
Completed |
NCT04124640 -
Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction.
|
||
Completed |
NCT00995072 -
Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
|
N/A | |
Active, not recruiting |
NCT05168371 -
Cognitive-Behavioural & Mindfulness-Based Online Programs for Female Sexual Dysfunction
|
N/A | |
Completed |
NCT04384172 -
Effect of Peripheral Neuromodulation on Vaginal Blood Flow
|
N/A | |
Recruiting |
NCT06237166 -
Evaluation of an Online Intervention for Female Sexual Dysfunction
|
N/A | |
Completed |
NCT03463707 -
BP101 for Adults With Female Sexual Dysfunction
|
Phase 3 | |
Recruiting |
NCT01078077 -
The Impact of a Topical Vasodilating Cream on Female Sexual Experience
|
N/A | |
Completed |
NCT01724658 -
Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women
|
Phase 2 | |
Completed |
NCT02229721 -
Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women
|
Phase 2 | |
Completed |
NCT00479570 -
Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction.
|
Phase 2 | |
Not yet recruiting |
NCT06116045 -
Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder
|
Phase 2 | |
Withdrawn |
NCT02862184 -
Female Sexual Dysfunction, Risks and Outcomes (FSFI)
|
N/A | |
Completed |
NCT01195701 -
Clitoral Location in Relation to Sexual Function Using Pelvic Imaging
|
N/A | |
Completed |
NCT04484753 -
Validation of iPelvis App for Female Pelvic Floor Dysfunction
|
N/A |